Work

Durability of Responses on Continuous Therapy and Following Drug Cessation in Deep Responders with Venetoclax and Rituximab

Year: 2018

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2018-183

Authors: Danielle M. Brander, John F. Seymour, Shuo Ma, Mary Ann Anderson, Michael Y. Choi, Thomas J. Kipps, Kathryn Humphrey, Abdullah Masud, Ruby Nandam, Su Young Kim, Maria E. Verdugo, Andrew W. Roberts

Institutions: Duke Medical Center, The Royal Melbourne Hospital, Peter MacCallum Cancer Centre, Northwestern University, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Walter and Eliza Hall Institute of Medical Research, University of California San Diego, Moores Cancer Center, F. Hoffmann-La Roche AG, AbbVie (United States)

Language: English

Topic: Chronic Lymphocytic Leukemia Research

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2908422862

Cites:

Cited by: 7

Related to: 10